Filtered By:
Specialty: Cardiology
Condition: Patent Foramen Ovale

This page shows you your search results in order of relevance. This is page number 13.

Order by Relevance | Date

Total 614 results found since Jan 2013.

Controversies in Cardioembolic Stroke
Opinion statement Cardioembolic (CE) stroke mechanisms account for a significant number of ischemic strokes; however, the true burden is likely underestimated. It is critically important to identify patients with CE strokes because these individuals have high recurrence rates and represent a subgroup of patients who may benefit from targeted therapy in the form of anticoagulation or device based treatments. Current guidelines offer recommendations for diagnosis and treatment of these patients; however, important questions remain. First, appropriate cardiac testing in the setting of CE must be individualized and t...
Source: Current Treatment Options in Cardiovascular Medicine - November 9, 2014 Category: Cardiology Source Type: research

Prevention of recurrent cryptogenic stroke with percutaneous closure of patent foramen ovale; one year follow-up study with magnetic resonance imaging and Holter monitoring.
CONCLUSION: One-year clinical and MRI follow-up study of patients with cerebral ischemic events and percutaneous closure of PFO showed no recurrent event and no significant complication associated with the procedure. In addition, Holter monitorization demonstrated that the procedure did not increase the incidence of arrhythmias compared with pre-procedural monitoring. PMID: 25655849 [PubMed - in process]
Source: Turk Kardiyoloji Dernegi arsivi - January 1, 2015 Category: Cardiology Authors: Ateş AH, Sunman H, Aytemir K, Yorgun H, Canpolat U, Topcuoğlu MA, Karlı Oğuz K, Şahiner L, Kaya EB, Tokgözoğlu L, Kabakçı G, Oto A Tags: Turk Kardiyol Dern Ars Source Type: research

Diagnostic dilemmas in a patient with multivascular embolic stroke.
We describe a patient admitted to the intensive care unit with aphasia, which was due to an embolic ischaemic cerebral stroke associated with a previously unknown patent foramen ovale. Eventually, this finding during echocardiography led us to the diagnosis of pancreatic cancer. The thrombotic complications of pancreatic cancer, in combination with a large, patent foramen ovale, support the mechanism of a paradoxical embolism through the patent foramen ovale as the cause of cerebral ischaemic stroke. PMID: 26031637 [PubMed - as supplied by publisher]
Source: Netherlands Heart Journal - June 2, 2015 Category: Cardiology Authors: Delsing CP, van Duijnhoven M, Arnoldussen C, le Noble J Tags: Neth Heart J Source Type: research

Closing patent foramen ovale in cryptogenic stroke: The underscored importance of other interatrial shunt variants.
Abstract Recent trials and metanalysis even not fully conclusive and still debated, at least suggested that mechanical device-based closure of patent foramen ovale (PFO) is more effective than medical therapy in prevent recurrence of stroke. In a proportion ranging from 20% to nearly 40% of patients in literature, PFO is associated to atrial septal aneurysm (ASA): ASA is a well-known entity often associated with additional fenestration. Additionally small atrial septal defects ("Flat ASD") can present with signs of paradoxical embolism and cannot be easily detected by transthoracic echocardiography or even by tran...
Source: World Journal of Cardiology - June 26, 2015 Category: Cardiology Authors: Rigatelli G, Rigatelli A Tags: World J Cardiol Source Type: research

Potential Utility of Multidetector Computed Tomography to Identify both Cardiac Embolic Sources and Coronary Artery Disease in Patients with Embolic Stroke
Conclusions: Our results suggest that MDCT has potential to identify both cardiac embolic sources and CAD in patients with embolic stroke but without known CAD.Cardiology 2016;133:205-210
Source: Cardiology - November 30, 2015 Category: Cardiology Source Type: research

Transcatheter closure of PFO as secondary prevention of cryptogenic stroke.
This article covers the main unsolved issues regarding the potential role that the patent foramen ovale (PFO) plays in the genesis of so-called cryptogenic stroke. Some brief notions of the anatomy and epidemiology of the PFO are outlined. Subsequently, the results of the three trials on secondary prevention (medical therapy vs. transcatheter closure) in patients with PFO and a history of cryptogenic stroke are presented. The conflicting results of numerous meta-analyses derived from the three randomized controlled trials are discussed. Official scientific guidelines dispute an alleged superior efficacy of transcatheter P...
Source: Herz - June 5, 2016 Category: Cardiology Tags: Herz Source Type: research

Atrial dyssynchrony and left atrial stiffness are risk markers for cryptogenic stroke in patients with patent foramen ovale
ConclusionIn conclusion, we demonstrated that LASt and atrial dyssynchrony might be risk markers of cryptogenic stroke in patients with PFO.
Source: Echocardiography - September 1, 2017 Category: Cardiology Authors: Ragab A. Mahfouz, Waleed S. Alawady, Abdelhakem Salem, Adel S. Abdelghafar Tags: ORIGINAL INVESTIGATION Source Type: research

Meta-Analysis Comparing Patent Foramen Ovale Closure Versus Medical Therapy to Prevent Recurrent Stroke
It is unknown if closure of a patent foramen ovale (PFO) plus medical therapy (MT; antiplatelet or anticoagulation) is superior to MT alone to prevent recurrent cryptogenic stroke. We performed a meta-analysis of randomized controlled trials (RCT) that compared PFO closure plus MT to MT alone in patients with cryptogenic stroke. The efficacy endpoints were recurrent stroke, transient ischemia attack (TIA), and death. The safety endpoints were major bleeding and newly-detected atrial fibrillation (AF).
Source: The American Journal of Cardiology - December 11, 2017 Category: Cardiology Authors: Tomo Ando, Anthony A. Holmes, Mohit Pahuja, Arshad Javed, Alenxandros Briasoulis, Tesfaye Telila, Hisato Takagi, Theodore Schreiber, Luis Afonso, Cindy L. Grines, Sripal Bangalore Source Type: research

Meta-Analysis Comparing Patent Foramen Ovale Closure Versus Medical Therapy to Prevent Recurrent Cryptogenic Stroke
New evidence suggests that closure of a patent foramen ovale (PFO) plus medical therapy (MT; antiplatelet or anticoagulation) is superior to MT alone to prevent recurrent cryptogenic stroke. We performed a meta-analysis of randomized controlled trials that compared PFO closure plus MT with MT alone in patients with cryptogenic stroke. The efficacy end points were recurrent stroke, transient ischemia attack, and death. The safety end points were major bleeding and newly detected atrial fibrillation.
Source: The American Journal of Cardiology - December 11, 2017 Category: Cardiology Authors: Tomo Ando, Anthony A. Holmes, Mohit Pahuja, Arshad Javed, Alenxandros Briasoulis, Tesfaye Telila, Hisato Takagi, Theodore Schreiber, Luis Afonso, Cindy L. Grines, Sripal Bangalore Source Type: research

Meta-Analysis of Randomized Controlled Trials on Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Prevention of Cryptogenic Stroke
The optimal management of patients with cryptogenic stroke (CS) and patent foramen ovale (PFO) remains controversial. We conducted a meta-analysis to assess the effect of PFO closure for secondary prevention of stroke in patients with CS. We searched the literature for randomized clinical trials (RCTs) assessing the recurrence of stroke after PFO closure when compared to medical therapy (antiplatelet and/or anticoagulation). Five RCTs with a total of 3440 patients were included. The mean age was 45.2 ±9.7 years and follow-up duration ranged from 2 to 5.9 years.
Source: The American Journal of Cardiology - March 2, 2018 Category: Cardiology Authors: Aiman Smer, Mohsin Salih, Toufik Mahfood Haddad, Raviteja Guddeti, Abdulghani Saadi, Alok Saurav, Ram Belbase, Mohamed Ayan, Mahmoud Traina, Venkata Alla, Michael Del Core Source Type: research

Meta-analysis of Randomized Controlled Trials on Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Prevention of Cryptogenic Stroke
The optimal management of patients with cryptogenic stroke (CS) and patent foramen ovale (PFO) remains controversial. We conducted a meta-analysis to assess the effect of PFO closure for secondary prevention of stroke on patients with CS. We searched the literature for randomized control trials assessing the recurrence of stroke after PFO closure compared with medical therapy (antiplatelet and/or anticoagulation). Five randomized control trials with a total of 3,440 patients were included. The mean age was 45.2  ± 9.7 years and follow-up duration ranged from 2.0 to 5.9 years.
Source: The American Journal of Cardiology - March 2, 2018 Category: Cardiology Authors: Aiman Smer, Mohsin Salih, Toufik Mahfood Haddad, Raviteja Guddeti, Abdulghani Saadi, Alok Saurav, Ram Belbase, Mohamed Ayan, Mahmoud Traina, Venkata Alla, Michael Del Core Source Type: research

Predicted Impact of Recent Patent Foramen Ovale Closure Trials on Management of Cryptogenic Stroke
Background: The indication for percutaneous closure of patent foramen ovale (PFO) has recently changed, following evidence that closure is superior to medical treatment alone in preventing recurrent stroke in cryptogenic stroke patients aged ≤60 years. We aimed to determine the impact of updated criteria on the management of stroke or transient ischemic attack (TIA) at our institution.
Source: Heart, Lung and Circulation - June 23, 2019 Category: Cardiology Authors: P. Trevella, L. Sanders, D. Jin, J. Gutman, MacA. Isaac, S. Palmer Tags: 667 Source Type: research

Atrial Septal Defect and the Risk of Ischemic Stroke in the Perioperative Period of Noncardiac Surgery
Stroke is a serious complication of non-cardiac surgery. Congenital defects of the interatrial septum may be a potent risk factor for perioperative stroke. The aim of the present study was to determine the association between atrial septal defect (ASD) or patent foramen ovale (PFO) and in-hospital perioperative ischemic stroke after non-cardiac surgery in a large nationwide cohort of patients hospitalized in the United States. Patients undergoing noncardiac surgery between 2004 and 2014 were identified using the Healthcare Cost and Utilization Project's National Inpatient Sample.
Source: The American Journal of Cardiology - July 14, 2019 Category: Cardiology Authors: Nathaniel R. Smilowitz, Varun Subashchandran, Jeffrey S. Berger Source Type: research

Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source
CONCLUSIONS: Infratentorial lesions may be independently associated with PFO in patients with ESUS. The presence of infratentorial lesions could predict the presence of PFO in ESUS cases.PMID:33952811 | DOI:10.5551/jat.61200
Source: Journal of Atherosclerosis and Thrombosis - May 6, 2021 Category: Cardiology Authors: Kentaro Ishizuka Sono Toi Takao Hoshino Eiko Higuchi Kazuo Kitagawa Source Type: research